Adam K. Stern
Independent DirectorMr. Adam K. Stern was MD and Head of Merchant & Venture Banking of ThinkEquity, LLC from February 2026 to 2026 and serves as its Head of Private Equity, Merchant & Venture Banking (MVB) ThinkStern Ventures since 2026. He had been a Director of Western Acquisition Ventures Corp. since January 12, 2022, until December 28, 2023. He has been an Independent Director of VivoSim Labs, Inc. (formerly known as Organovo Holdings, Inc.) since July 14, 2020. Mr. Stern has been a Director of DarioHealth Corp. since March 1, 2020. He had been the Head of Private Equity Banking at Aegis Capital Corp., since 2012 until February 2026. Mr. Stern had been the Chief Executive Officer of SternAegis Ventures since December 2012. He has great venture capital and investment banking experience focusing primarily on the technology and life science sectors of the capital markets. He was a member of board of directors at DarioHealth Corp. between October 2011 and May 2014. Mr. Stern served as a Senior Managing Director at Augment Securities, Inc. (formerly, Spencer Trask Ventures, Inc.) from 1997 to November 2012, where he managed the structured finance group focusing primarily on the technology and life science sectors and served as its Managing Director. He served as a Senior Managing Director at Spencer Trask Private Equity Fund I, LP. He joined Spencer Trask in September 1997. From 1989 to 1997, Mr. Stern was at Josephthal & Co., Inc., Members of the New York Stock Exchange, where he served as Senior Vice President, Head of Private Equity and Managing Director and held increasingly responsible positions from 1989 to 1997. Mr. Stern had been a Director of Matinas BioPharma Holdings, Inc. since July 2013 until November 2, 2020. He served as a Director of Amplifica Holdings Group, Inc. until July 2026, Matinas Biopharma, Inc. and Dance Biopharm Inc. He was Director at HydroFarm Holdings Inc. He was Director at Adgero Biopharmaceuticals. He is Member of the Board of Directors of Western Acquisition Ventures Corporation and Aerami Therapeutics (formerly, Dance Biopharm Holdings, Inc.). He has been a Director of OPKO Biologics since November 11, 2012. He serves as a Member of Advisory Board of The Haft Group Inc. He served as a Director of InVivo Therapeutics Holdings Corp. from October 2010 to May 23, 2013 and VivoSim Labs, Inc. (formerly known as Organovo Holdings, Inc.) from February 2012 to June 06, 2013. He served as a Director at Prolor Biotech. Previously, he served as a Director at OPKO Biologics from May 2007 to June 7, 2011. He has been a FINRA licensed Securities Broker since 1987 and a Registered General Securities Principal since 1991. Mr. Stern holds a Bachelor of Arts degree with honors from The University of South Florida Muma College of Business in Tampa in 1987. Mr. Stern graduated from the Lear School, Miami Florida in 1982.
Positions
- Company NameVivoSim Labs, Inc.Stock CodeVIVSPositionIndependent DirectorColleagues
- KEKeith E. MurphyExecutive Chairman & Corporate Secretary
- NSNorman StaskeyPresident, CFO & Principal Financial Officer
- AAAmar A. SethiChief Scientific Officer
- TLTony LialinChief Commercial Officer
- DJDouglas Jay CohenLead Independent Director
- DGDavid GobelIndependent Director
- ATAlison Tjosvold MilhousIndependent Director
